Shares of Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) saw unusually-high trading volume on Wednesday . Approximately 5,489,741 shares changed hands during trading, an increase of 238% from the previous session’s volume of 1,624,192 shares.The stock last traded at $3.79 and had previously closed at $3.68. Analyst Upgrades and Downgrades AUTL has been the […]
Autolus Therapeutics (NASDAQ:AUTL – Free Report) had its price objective increased by Truist Financial from $10.00 to $11.00 in a report issued on Tuesday morning, Benzinga reports. They currently have a buy rating on the stock. A number of other brokerages have also commented on AUTL. The Goldman Sachs Group upped their target price on […]
Wealth Effects LLC trimmed its stake in shares of Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) by 8.5% in the 4th quarter, HoldingsChannel reports. The firm owned 43,000 shares of the company’s stock after selling 4,000 shares during the quarter. Wealth Effects LLC’s holdings in Autolus Therapeutics were worth $277,000 at the end of the […]
Wealth Effects LLC reduced its stake in Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) by 8.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 43,000 shares of the company’s stock after selling 4,000 shares during the period. Wealth Effects LLC’s […]
Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) shares gapped up before the market opened on Monday . The stock had previously closed at $6.32, but opened at $6.48. Autolus Therapeutics shares last traded at $6.43, with a volume of 82,925 shares changing hands. Wall Street Analysts Forecast Growth AUTL has been the subject of […]